drugset / Trial / NCT00516113
A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria
Phase 4
Completed
24 enrolled
Karolinska Institutet
GlaxoSmithKline · collabGöteborg University · collabNovo Nordisk A/S · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The objective of this study is to explore the onset of action when serotonin reuptake inhibitors are used to treat premenstrual dysphoric disorder
Timeline
- Start
- 2000-10
- Primary completion
- —
- Completion
- 2002-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Paroxetine | Small molecule | 20 mg | — |